chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a Registered Nurse concerning a 25 year old female patient with no pertinent medical history and no drug reactions or allergies who on 15-MAY-2009 was vaccinated with a first dose of GARDASIL (Lot # 658271/0558X) 0.5ml intramuscularly in the upper left arm. Concomitant therapy included SEASONALE. On 16-MAY-2009 the patient experienced severe arm pain and soreness from the injection site and down the arm. There was slight numbness. On 15-MAY-2009 pregnancy test was performed and was negative. On 19-MAY-2009 the patient went to the emergency room for flu like symptoms and the arm pain. She was given TORADOL for pain. On 20-MAY-2009 the patient recovered. Follow up information from a certified medical assistant revealed that the patient received no other vaccines at the time of the GARDASIL. The patient went to the Urgent Care Center on 19-MAY-2009. Charts showed EKG and lab work done there were normal. Additional information is not expected.
Ringing in ears; committed suicide; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient committed suicide because of the ringing in his ears. 6 months after the patient got the vaccine, he committed suicide because the ringing in his ears drove him crazy. The patient received the Pfizer covid vaccine. The outcome of the events was unknown.   Information about batch/ lot number has been requested
Information has been received from a consumer concerning her daughter who on an unspecified date was vaccinated with a dose of RECOMBIVAX HB (manufacturer unknown) (route and lot # unknown) and with a dose of PEDVAXHIB (manufacturer unknown) (route and lot # unknown). Other concomitant therapy included PEDIARIX. Subsequently, on an unspecified date, the patient experienced side effects after receiving the vaccines. It was unspecified if the patient sought medical attention. At the time of the report the patient's outcome was unknown. No further information is available.
None. Gave Moderna instead of PFIZER  -Was supposed to be Pfizer (FoR 2nd  vaccination)
Pt mother called stating the arm where shots were given L is red, swollen, looks like blisters, shots were given 6/18/07
local fever, limited to upper arm. Began at time of vaccination. Developed intense itchiness two hours after shot. Arm swelled significantly, continued to itch and be very hot after 48 hours. Treated with chilren's strength Motrin. One dose soon after vaccine, second dose accompanied by an oral antihistimine at 55 hours.
Shortly after my vaccine, I develop ptosis in my left eye. I was diagnosed with autoimmune disease and Psoriasis.
pt c/o tenderness @ site of inj p/pt was immunized;7 days later pt devel a fine pimple type rash sl red in color;in folds of body & thighs;pt c/o pruritus on bottom of feet;devel rash that resembled mosquito bites in later day;
Patient's sugar levels skyrocketed to 553 from a previous day of 170. Patient generally stays within sugar control of 120-170.
chills; body aches; This is a spontaneous report from a contactable consumer via Pfizer Sales Representative.   A 41-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on an unknown date at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. Historical vaccination included first dose of BNT162B2 on an unknown date at single dose for COVID-19 immunisation. Patient had chills and body aches after receiving second dose. Outcome was unknown. No follow-up attempts are possible; Information about Lot/Batch cannot be obtained.
Severe pain in left hip, then in right hip then buttocks then  to shoulders and arms.  Could barely move arms and legs because of the pain.  First Dr. took xrays and gave Rx pain medications, but they didn't work.  Second Dr. took detailed blood tests.  The diagnosis was POLYMYALGIA RHUMATICA, a disease specific to the elderly and those with specific descent.  Affects the hip girdle and shoulder girdle.  Is linked to a virus and the Covid mRNA vaccine.  Specific treatment is Prednisone, which affected the symptoms immediately.  A friend has the exact same symptoms, one week after the second dose of the vaccine.  He continues to suffer.  Complication is Arteritis
The patient was vaccinated with first dose of Rabavert in January, returned two months later for second dose; Case reference number US-BN-2023-000665 is a spontaneous case report initially received from health care professional via Communication (reference number: USBAV23-0523) on 12-Apr-2023 and concerns a patient of unknown age and gender.  The patient's relevant medical history and concomitant medication details were not provided.  On an unspecified day in January, a patient was vaccinated with the first dose of Rabavert vaccine (batch number not provided) at an unknown dose, route, or site of administration, for unknown indication.  On an unspecified day, reported as two months after the first dose of Rabavert, the patient returned for second dose (explicitly coded as 'incomplete course of vaccination').  At the time of this report, it was unknown if the patients experienced any adverse event due to Rabavert.  Additional information received from on 13-Apr-2023 included local case ID.; Reporter's Comments: A patient of unknown age and gender was vaccinated with the first dose of Rabavert vaccine for unknown indication and reportedly two months later the patient returned for second dose, which is considered as incomplete course of vaccination. No associated adverse events were reported. Incomplete course of vaccination is listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to Rabavert, but to a human factor. The case is non-serious.; Sender's Comments: A patient of unknown age and gender was vaccinated with the first dose of Rabavert vaccine for unknown indication and reportedly two months later the patient returned for second dose, which is considered as incomplete course of vaccination. No associated adverse events were reported. Incomplete course of vaccination is listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to Rabavert, but to a human factor. The case is non-serious.
Erythematous, hot, induration on both thighs and left upper arm. Afebrile. Prescribed Bactrim and Benadryl by MD.
1500 injection.   1508 began to feel dizziness, tingling in hands, warmth and numbness, pulsed dropped to 50 color pale, vitals 135/115 has not had anything to eat since 9am
Facial redness/swelling, low grade fever.  cold like symptoms onset one day after vaccination
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 69-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Feb2021 at 12:00 as dose 1, single (Batch/Lot number: unknown), in right arm, as dose 2, single (Batch/Lot number: unknown), in right arm, on 03Sep2021 at 12:00 as dose 3 (booster), single (Batch/Lot number: unknown), in right arm and on 28Feb2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 69 years, in right arm for Covid-19 immunisation. The patient's relevant medical history included: "Heart disease Asthma" (unspecified if ongoing), notes: Heart disease Asthma; "Heart disease Asthma" (unspecified if ongoing), notes: Heart disease Asthma; "COVID-19" (unspecified if ongoing). Concomitant medication(s) included: PAXLOVID taken for Covid-19, start date: 12Apr2022, stop date: 17Apr2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 22Apr2022, outcome "not recovered" and all described as "Treatment of COVID-19". It was unknown if therapeutic measures were taken as a result of drug ineffective, Covid-19. Adverse event: After taking full dosage she tested negative for four days. On the fifth day she had cold like symptoms again and tested positive. Patient had no known allergies. No other medication in 2 weeks. Lot numbers were misplaced/discarded. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt received 2nd dose of Moderna and had dizziness upon standing  15 minutes after dose, sx resolve w no tx
Discharge Provider: MD Primary Care Provider: NP Admission Date: 3/24/2023 Discharge Date: 3/29/2023 PRESENTING PROBLEM: Acute on chronic respiratory failure with hypoxia and hypercapnia  [J96.21, J96.22] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 65 y.o. female with a pertinent past medical history of COPD on 4-6L NC baseline, constrictive CM (EF 57% 5/22), chronic diastolic HF s/p biventricular pacemaker placement, hx TR s/p mechanical tricuspid valve replacement in 2010 on coumadin, paroxysmal Afib, CKD3, morbid obesity, HTN and hypothyroidism who was admitted on 3/24 for AHHRF due to COVID-19 and an acute exacerbation of heart failure.   The patient began to feel more short of breath about 3 days prior to admission with increased cough, rhinorrhea, and chills.  She also had to increase her home oxygen from baseline of 4-6 L to 6 L or more.  On admission, she was hypoxic, and did require BiPAP.  Testing was positive for COVID-19 virus, which is likely the cause of her worsening of her baseline chronic respiratory failure.  Inpatient, she was also significantly diuresed with assistance of Cardiology.  Her home medications were changed as well, as she continued to diurese well below her dry weight.  Her previous dry weight was thought to be 131 kg, but upon discharge, she was 124 kg on 3/29/2023.  She was eventually able to be weaned back to her home baseline oxygen needs of 4 L nasal cannula.  On 03/29, patient's symptoms overall has significantly improved.  No significant shortness of breath or new/worsening chest pain.  Stable for discharge back to facility with outpatient therapy services .       Of note, did stop the patient's home Diamox, and given her chronic hypercarbia, this medication should not be considered for use in this patient in the future.
Severe headache within 10 min of injection.  Within 2 hours, fever, chills, extreme aches, sleeplessness.  Next morning, woke up to dizziness and fatigue.  After 2 days, ok.  Day 8 redness around injection site and minor pain, but severe itch.
One week post vax, pt developed a rash around the injection site. It appeared to be that of a red, raised bump appearance of varicella. The rash seemed to disappear or lessen and then reappear at a different location. The rash occurred over a 3 week period. The rash spread from the right leg to the left leg which was raised bumps too numerous to count. Later the rash went to the arms, face and trunk areas. This rash was of a few red bumps only. The pts temperature for the 3 week period was between 99 and 100F. On 7/11/00, the child was assessed at our clinic and the pt has a fine rash on both legs. No treatment was given.
PT RECEIVED VACCINE AND AFTER 15 MINUTES SHE BEGAN TO STATE THERE WAS TINGLING IN ARMS AND FACE/LIPS. I KEPT THE PATIENT FOR ABOUT AN EXTRA 10 MINUTES AND AFTERWARDS SHE BEGAN ITCHING AND STARTED TO STATE THROAT STARTED TO SWELL UP AND LIPS WERE TINGLING, SHE BEGAN TO SCRATCH HER ARMS.  PT WAS GIVEN ORAL LIQUID BENADRYL 50MG (20ML)
Tireness, Sore Arm, Muscle Aches, Fever, Headache
2 months following second vaccine patient developed severe plaque psoriasis.  She was 70 years old and never had psoriasis before.
Dizziness, Headache, Myalgia, Fever, HYPERtension, Pt reported "body felt hot while hands/feet were very cold." Subjective fever, did not take temp., reported loss of taste, PCR covid tested on 12/30/2020 results negative Narrative: Pt remained at home and self-managed symptoms with OTC medications x48 hours. Reported for work approximately 72 hours after vaccine with no further issues reported. Had PCR covid test completed 12/20/2020 with negative results.
Large red circle over 2 inches and itching. Redness was approximately 4 inch in diameter.
I had a Covid-vaccination Booster shot (Pfizer) yesterday. I have chest pain today. I didn't have that symptom in the previous two shots. Is there anything that I can do for it?
RASH; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.   No concomitant medications were reported. On an unspecified date, the subject experienced rash. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of rash was not reported. This report was non-serious.
Information has been received from a health care worker concerning unknown number of patients of unknown demographics. On unspecified dates, the patients were inadvertently vaccinated with improperly stored GARDASIL (confirmed not GARDASIL 9) (dose, route, lot number and expiration date were unspecified). No adverse effects were reported. Additional information has been requested.
Post vax, the pt began to push away when held, refused comforting, no eye contact, screamed when touched/handled, and had no recognition of own parents. Dx with autism.
I was given a pneumonia and flu shot one in each arm.  After about 20 minutes my throat got a little hoarse and I had a slight head ache which has happened before.  Later that early evening I was extremely chilled with my feet and arms going numb.  I started feeling "sick" all over with aches in my joints and muscles.  I went to be early then woke up a few hours later with discomfort in my chest and very dizzy.  I rushed to the bathroom with violent retching.  I started to feel a little better after that.  I was weak and achy for the next day then slowly got better.
inappropriate schedule of vaccine administered; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 088D21A and 054C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION. On 20-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION had resolved. Not Provided          No concomitant medications information was reported. No treatment medications were provided.   This case was linked to MOD-2021-289785 (Patient Link).
Felt sick after vaccination; This spontaneous report has been received from a lawyer, via plaintiff fact sheet from a case in litigation for zoster vaccine live (ZOSTAVAX)(MARRS # 2009USA005959), concerning to a male Elderly patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not reported.   On an unknown date in 2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (manufacturer unknown) (anatomical location, administration route, lot number and exporation date were not rpeorted) for prophylaxis.         On an unspecified date, the patient felt sick after the vaccination (malaise). The outcome of malaise was unknown.   The reporter considered malaise as an adverse reaction or side effect from the vaccination with pneumococcal vaccine, polyvalent (manufacturer unknown).; Sender's Comments:  US-009507513-2009USA005959:
Patient was given the vaccination at 12 weeks gestation; provider was aware of pregnancy at time of vaccination. Error was not discovered/reported to administration until 12/18/19. Patient has had a normal/problem-free pregnancy so far and has not had any adverse events. Patient is being monitored by high-risk pregnancy facility due to her age and comorbid conditions that require she takes medications throughout pregnancy. The high-risk facility has been notified of the vaccine error.
Client was diagnosed with R AOM the day (2/16/06) she was given MMR, and was started on omnicef. Approximately 7-9 days later she developed fevers x 2 days followed by a macular papular rash over trunk  and extremities , sparing palms & soles. No N/V/D. Rash was blanchable. Petechiae were seen on buccal mucosae and anterior soft palate. TM's had yellow fluid but good mobility with insuflation and good landmarks noted. Mild irritability, but great P.O. liquids.  Supportive care only.
Period starting and stopping blood clots; Period starting and stopping blood clots; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (Period starting and stopping blood clots) and BLOOD DISORDER (Period starting and stopping blood clots) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 425) for COVID-19 vaccination.     Medical history include Latex amatryptelin.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form once. On 24-Jun-2021, the patient experienced MENSTRUATION IRREGULAR (Period starting and stopping blood clots) and BLOOD DISORDER (Period starting and stopping blood clots). At the time of the report, MENSTRUATION IRREGULAR (Period starting and stopping blood clots) and BLOOD DISORDER (Period starting and stopping blood clots) had not resolved.            No Concomitant medications were received by the reporter. Treatment medication for these events were not reported by the reporter.
Markedly bnormal stress echo-cardiogram about 4 hours following Covid vaccination.
experienced / fatigue; muscle aches; stiff neck; pain in right part of her back / continues today/ on the right side of her lower back; next day she could not get out of bed.; This case was reported by a consumer via call center representative and described the occurrence of low back pain in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included apixaban (Eliquis) for atrial fibrillation.   The patient's past medical history included shingles (In September 2020, had full blown shingles), pain (In September 2020, experienced pain and rash on the lower left side, pain lasted for 3 months) and rash. Previously administered products included Shingrix with an associated reaction of atrial fibrillation (1st dose received at the end of January 2021, reference case US2021125167) and COVID Vaccine (received 2 doses on an unknown date (did not specify which one), sometime after receiving the 1st dose of Shingrix, but before receiving the 2nd dose of Shingrix.).   In May 2021, the patient received the 2nd dose of Shingrix and Eliquis at an unknown dose and frequency. In May 2021, 1 day after receiving Shingrix, the patient experienced low back pain and activities of daily living impaired. On an unknown date, the patient experienced fatigue, muscle pain and stiff neck. The action taken with Eliquis was unknown. On an unknown date, the outcome of the low back pain was not recovered/not resolved and the outcome of the activities of daily living impaired, fatigue, muscle pain and stiff neck were unknown.   It was unknown if the reporter considered the low back pain, activities of daily living impaired, fatigue, muscle pain and stiff neck to be related to Shingrix.  Additional details were provided as follows:  The patient had reported the case for herself. The patient was prescribed Eliquis to treat atrial fibrillation and took her first dose of Eliquis on the same day prior to receiving the 2nd dose of the Shingrix vaccine. The patient received 2nd dose of Shingrix 3 weeks ago from the reporting date on an unknown arm. The next day patient could not get out of bed and stated that the day after she developed pain on the right side of her lower back and stated that the pain was the same type of pain that she experienced when she had Shingles in September 2020.  Less than 3 weeks after receiving Shingrix and Eliquis, the patient experienced fatigue, muscle pain and stiff neck. The patient was still in a lot of pain since receiving the 2nd dose. It was unknown if the reporter considered the low back pain, activities of daily living impaired, fatigue, muscle pain and stiff neck to be related to Eliquis. The reporter consented to follow-up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021125167:same reporter, same patient - (1st dose)
pt recv vax; arm hurt; lots of redness; fever 101; swelling & itching; 3 days of discomfort;
The 4th day, post vax, pt began with chills and high fever. By bedtime fever was 101F-102F. Chills and fever lasted 3 days. It was 100.2F on 3rd day. Had tight chest and cough that led to chronic (2 week) upper respiratory symptoms; loose cough, thick expectorant (yellow to white).
Received 1st of 2 Pfizer vaccines on 1/29/21 around noon. Within 6 hours of injection, developed severe  itching of the left chest area. No redness or inflammation at the injection site in arm ever. By the next morning, he had developed a widespread raised, red, pruritic rash on his chest, abdomen,thighs and buttocks. He didn't tell me, (his wife) until 2/11 and never reported it as not sure who to report it to. I insisted he call his PCP but we had the severe winter storm, power outages and many businesses were closed or not available. He is due for the second vaccine on 2/21/21 however the rash persists. He has been taking Allegra daily to decrease the itching.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 67-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported but it could be 66 or 67 years. About 2 months before the date of reporting, the patient received SHINGRIX and all she had was a sore arm. For tolerance to 2nd dose, refer case US2019GSK054543.